Using biomarkers to detect oral cancer holds potential for saving lives when the cancer is most curable.
Ge
G
Jin
D015415:Biomarkers / Q000097:blood / Q000378:metabolism*; D002294:Carcinoma, Squamous Cell / Q000175:diagnosis* / Q000453:epidemiology / Q000378:metabolism; D004815:Epidermal Growth Factor / Q000378:metabolism; D066246:ErbB Receptors / Q000378:metabolism; D004919:Erythroplasia / Q000175:diagnosis / Q000378:metabolism; D006801:Humans; D007972:Leukoplakia, Oral / Q000175:diagnosis / Q000378:metabolism; D009062:Mouth Neoplasms / Q000175:diagnosis* / Q000453:epidemiology / Q000378:metabolism; D011230:Precancerous Conditions / Q000175:diagnosis / Q000378:metabolism; D011379:Prognosis; D016211:Transforming Growth Factor alpha / Q000378:metabolism; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism; D023083:beta-Defensins / Q000097:blood / Q000378:metabolism
D015415:Biomarkers; C406407:DEFB1 protein, human; C422950:DEFB103A protein, human; C106641:DEFB4A protein, human; D016211:Transforming Growth Factor alpha; D016159:Tumor Suppressor Protein p53; D023083:beta-Defensins; D004815:Epidermal Growth Factor; C512478:EGFR protein, human; D066246:ErbB Receptors